For hospitals, pharmacies and procurement teams
Medrack coordinates access to prescription oral oncology medicines. This page is for oncology pharmacy, procurement and clinical teams who need a medicine that is hard to obtain locally, whether for one patient or as a recurring requirement.
What Medrack does
We are a referral and sourcing coordinator. We work from a written prescription or a documented institutional requirement, assess whether an appropriate route exists for that medicine and that destination, and coordinate documentation and supply where one does.
The portfolio
28 oral oncology molecules across breast, prostate, lung, blood, kidney, liver, thyroid, gastrointestinal, brain and ovarian indications. Every one is prescription-only. None requires a cold chain, so nothing in the portfolio brings a refrigeration or temperature-excursion problem with it.
We source from established Indian manufacturers, among them Natco, Cipla, Zydus, Sun Pharmaceutical, Alkem, Glenmark and BDR Pharmaceuticals, and from originator companies including AstraZeneca, Novartis and Bayer where no generic exists. Five of the 28 are supplied as originator products under the brand the originator markets in India.
The full portfolio is a document rather than a public page. It lists every molecule with strengths, form, reference brand and supply type, and it is issued to a named recipient rather than published.
Request the portfolioBrowse the public catalogue
Where an institutional enquiry can come from
An enquiry can come from anywhere in the world. Many come from a family member arranging medicine for a patient who is being treated in another country. Many come from hospital pharmacy and procurement teams enquiring on behalf of a named patient.
Your own location is not what decides the answer. What matters is where the patient is being treated, because that is what determines whether a lawful route exists and what documentation it requires.
What we can assess
- A named-patient requirement where a medicine is not available locally
- Several medicines assessed together as one institutional enquiry
- A recurring requirement for a medicine your pharmacy already dispenses
- A specific strength or pack that your usual supplier cannot obtain
We assess. We do not confirm supply, price or timing before that assessment is done, and we say so in writing either way.
What to include in an institutional enquiry
The more of this you can give at the outset, the faster and more useful the reply. Incomplete enquiries are not refused, they are simply slower.
- Organisation name, type and country, and the facility the medicine is for
- Your name, role and a direct contact
- Medicine, strength, quantity, and whether the requirement is one-off or recurring
- The treating clinician or the institutional basis for the requirement
- Who would hold the import permission in your country, if you already know
- Any documentation your procurement process requires from a counterparty
Do not send patient-identifiable clinical detail in a first email. If a specific patient case is involved, say so and we will explain how to send it.
How an institutional enquiry progresses
- Enquiry. You send the requirement and the details above.
- Assessment. We check whether an appropriate route exists for that medicine and that destination.
- Written response. We reply with what we can confirm. Where a route exists, the response identifies the dispensing pharmacy and the country.
- Documentation. Manufacturer, country of origin and batch details are confirmed in writing before anything proceeds.
- Dispatch and handover. Only after the preceding four are complete.
Nothing is dispatched and nothing is charged before a written response and your agreement to it.
What we cannot tell you before an assessment
Price. We do not publish prices. Cost depends on strength, quantity, the manufacturer available at the time and the destination.
Availability. A listing means we source that medicine. It does not mean stock today.
Lead time. Until a route is confirmed for a specific destination, any date would be a guess.
Regulatory clearance in your country. Import permission is held locally, by you or by a licensed importer you appoint. We can tell you what documentation we can provide. We cannot tell you that your regulator will accept it.
Who operates this service
| Operating name | Medrack |
|---|---|
| Registered name | A to Z Link |
Send an institutional enquiry
Use the form below. It reaches our team directly and gives you a reference you can quote. If you only want the portfolio document, choose that option and skip the medicine details.